4
Changes in Ownership
AMARIN CORP PLCUK Filed Acc 0001562180-21-000647
Chief Scientific Officer sold 421,629 shares at an average $8.01 ($3,378,131)
- Chief Scientific Officer acquired 320,026 shares (option exercise)
- Chief Scientific Officer gave up 21,535 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ketchum Steven B Chief Scientific Officer | 2021-01-27 | Option exercise | +25,389 | $1.02 | $25,897 | 556,893 | D: show line 1 in the form |
| Ketchum Steven B Chief Scientific Officer | 2021-01-27 | Option exercise | +8,332 | $2.50 | $20,830 | 565,225 | D: show line 2 in the form |
| Ketchum Steven B Chief Scientific Officer | 2021-01-27 | Option exercise | +5,797 | $2.50 | $14,493 | 571,022 | D: show line 3 in the form |
| Ketchum Steven B Chief Scientific Officer | 2021-01-27 | Option exercise | +52,938 | $2.50 | $132,345 | 623,960 | D: show line 4 in the form |
| Ketchum Steven B Chief Scientific Officer | 2021-01-27 | Option exercise | +29,427 | $2.50 | $73,568 | 653,387 | D: show line 5 in the form |
| Ketchum Steven B Chief Scientific Officer | 2021-01-27 | Option exercise | +23,436 | $1.40 | $32,810 | 676,823 | D: show line 6 in the form |
| Ketchum Steven B Chief Scientific Officer | 2021-01-27 | Option exercise | +47,605 | $2.95 | $140,435 | 724,428 | D: show line 7 in the form |
| Ketchum Steven B Chief Scientific Officer | 2021-01-27 | Option exercise | +85,313 | $3.80 | $324,189 | 809,741 | D: show line 8 in the form |
| Open-market sales · 421,629 sh · avg $8.01 · $3,378,131 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ketchum Steven B Chief Scientific Officer | 2021-01-27 | Option exercise · Stock Option (Right to Buy) | −25,389 | 0 | D: show line 17 in the form | ||
| Ketchum Steven B Chief Scientific Officer | 2021-01-27 | Option exercise · Stock Option (Right to Buy) | −8,332 | 0 | D: show line 18 in the form | ||
| Ketchum Steven B Chief Scientific Officer | 2021-01-27 | Option exercise · Stock Option (Right to Buy) | −5,797 | 16,703 | D: show line 19 in the form | ||
| Ketchum Steven B Chief Scientific Officer | 2021-01-27 | Option exercise · Stock Option (Right to Buy) | −52,938 | 0 | D: show line 20 in the form | ||
| Ketchum Steven B Chief Scientific Officer | 2021-01-27 | Option exercise · Stock Option (Right to Buy) | −29,427 | 164,573 | D: show line 21 in the form | ||
| Ketchum Steven B Chief Scientific Officer | 2021-01-27 | Option exercise · Stock Option (Right to Buy) | −23,436 | 0 | D: show line 22 in the form | ||
| Ketchum Steven B Chief Scientific Officer | 2021-01-27 | Option exercise · Stock Option (Right to Buy) | −47,605 | 11,082 | D: show line 23 in the form | ||
| Ketchum Steven B Chief Scientific Officer | 2021-01-27 | Option exercise · Stock Option (Right to Buy) | −85,313 | 31,687 | D: show line 24 in the form |
Loading xslF345X03/primarydocument.xml…